Retrospective analysis of the biopharmaceutics characteristics of solid oral Modified-Release drug products in approved US FDA NDAs designated as Extended-Release or Delayed-Release formulations.
Eur J Pharm Biopharm
; 193: 294-305, 2023 Dec.
Article
em En
| MEDLINE
| ID: mdl-37984592
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Polímeros
/
Biofarmácia
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article